dalteparin has been researched along with Respiratory Syndrome, Acute, Severe in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, W | 1 |
| Zhang, N | 1 |
| Guo, W | 1 |
| Gao, F | 1 |
1 other study available for dalteparin and Respiratory Syndrome, Acute, Severe
| Article | Year |
|---|---|
Combined pharmacotherapy for osteonecrosis of the femoral head after severe acute respiratory syndrome and interstitial pneumonia: two and a half to fourteen year follow-up.
Topics: Adult; Alendronate; Alprostadil; Bone Density Conservation Agents; Drug Therapy, Combination; Enoxap | 2018 |